bluebird bio Announces First Outcomes-Based Agreement with Medicaid for Sickle Cell Disease Gene Therapy
SOMERVILLE, Mass.--(BUSINESS WIRE)--Mar 11, 2024--
Source: eagletribune.com
Jess Rowlands News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jess Rowlands. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jess Rowlands Today - Breaking & Trending Today
Long-Term Data Presented at ASH Support beti-cel as a Potentially Curative Gene Therapy for β-Thalassemia Patients Who Require Regular Transfusions Through Achievement of Durable Transfusion Independence and Normal or Near-Normal Adult Hb Levels
SOMERVILLE, Mass.--(BUSINESS WIRE)--Dec 10, 2023--
Source: joplinglobe.com
Long-term Follow-up Data From bluebird's Gene Therapy Program in Sickle Cell Disease Support Durable, Potentially Curative Benefits Through Stable Production of Anti-Sickling Adult Hemoglobin and Resolution of Vaso-Occlusive Events | Business
SOMERVILLE, Mass.--(BUSINESS WIRE)--Dec 9, 2023--
Source: valdostadailytimes.com
New Sickle Cell Therapies Will Be Out of Reach Where They Are Needed Most
There is no clear path for African patients to get access to the treatments, which have multimillion-dollar price tags and are highly complex to manufacture and deliver.
Source: nytimes.com
bluebird bio Reports Third Quarter 2023 Financial Results and Highlights Operational Progress
SOMERVILLE, Mass.--(BUSINESS WIRE)--Nov 7, 2023--
Source: eagletribune.com